High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review

Overview

Journal Eur J Rheumatol

Publisher Aves

Specialty Rheumatology

Date 2024 Nov 22

PMID 39576169

Authors

Jozelio Freire de Carvalho

Thelma L Skare

Affiliations

Soon will be listed here.

Abstract

High-dose cyclophosphamide without stem cell rescue is a radical therapy for refractory autoimmune diseases. The objective was to review the results of high-dose cyclophosphamide without stem cell rescue in autoimmune diseases. PubMed, Scielo, and Embase databases were systematically searched for articles on high-dose cyclophosphamide without stem cell rescue treating autoimmune diseases between 1966 and September 2022. Twenty-nine studies were identified, including a total of 404 patients. The diseases most studied were systemic lupus erythematosus (n=113), multiple sclerosis (n=99), aplastic anemia (n=86), and myasthenia gravis (n=33). Most authors used the posology of 50mg/kg/day over four days of cyclophosphamide associated with Mesna, prophylactic antibiotics, G-CSF (granulocyte colony-stimulating factor), and support of red blood cells, and platelet transfusion. The most common side effects were febrile neutropenia, alopecia, and gastrointestinal complaints. Regarding outcomes, most of the studies demonstrated improvement of the underlying autoimmune disease, some long-lived, but relapses and failures were also identified. In conclusion, high-dose cyclophosphamide without stem cell rescue is an effective option for treating severe autoimmune diseases. This procedure is relatively safe when the appropriate supportive care measures are taken.

References

Brodsky R, SENSENBRENNER L, Jones R . Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood. 1996; 87(2):491-4. View

Brodsky R, Petri M, Smith B, Seifter E, Spivak J, Styler M . Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med. 1998; 129(12):1031-5. DOI: 10.7326/0003-4819-129-12-199812150-00007. View

Petri M, Jones R, Brodsky R . High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum. 2003; 48(1):166-73. DOI: 10.1002/art.10752. View

DeZern A, Styler M, Drachman D, Hummers L, Jones R, Brodsky R . Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases. Am J Blood Res. 2013; 3(1):84-90. PMC: 3555191. View

Lee S, Yoon J, Shin S, Park G, Min C . Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma. Immune Netw. 2013; 13(3):107-10. PMC: 3718921. DOI: 10.4110/in.2013.13.3.107. View

Lahouti A, Brodsky R, Christopher-Stine L . Idiopathic Inflammatory Myopathy Treated With High-Dose Immunoablative Cyclophosphamide--A Long-term Follow-up Study. JAMA Neurol. 2015; 72(10):1205-6. DOI: 10.1001/jamaneurol.2015.1425. View

de Bittencourt P, Gomes-da-Silva M . Multiple sclerosis: long-term remission after a high dose of cyclophosphamide. Acta Neurol Scand. 2005; 111(3):195-8. DOI: 10.1111/j.1600-0404.2005.00340.x. View

Nousari H, Brodsky R, Jones R, Grever M, Anhalt G . Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol. 1999; 40(5 Pt 1):750-4. DOI: 10.1016/s0190-9622(99)70157-x. View

Cohen M, Cohen J, Kerdel F . Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus. Int J Dermatol. 2002; 41(6):340-4. DOI: 10.1046/j.1365-4362.2002.01407.x. View

10.

Petri M, Brodsky R . High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosus. JAMA. 2006; 295(5):559-60. DOI: 10.1001/jama.295.5.559. View

11.

Gladstone D, Peyster R, Baron E, Friedman-Urevich S, Sibony P, Melville P . High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis: 2-year follow-up (investigational new drug No. 65863). Am J Ther. 2009; 18(1):23-30. DOI: 10.1097/MJT.0b013e3181b3ad95. View

12.

Brannagan 3rd T, Pradhan A, Heiman-Patterson T, Winkelman A, Styler M, Topolsky D . High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology. 2002; 58(12):1856-8. DOI: 10.1212/wnl.58.12.1856. View

13.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y . Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2016; 76(8):1327-1339. DOI: 10.1136/annrheumdis-2016-209909. View

14.

Krishnan C, Kaplin A, Brodsky R, Drachman D, Jones R, Pham D . Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. Arch Neurol. 2008; 65(8):1044-51. PMC: 2574697. DOI: 10.1001/archneurol.65.8.noc80042. View

15.

Schwartzman R, Simpkins N, Alexander G, Reichenberger E, Ward K, Lindenberg N . High-dose cyclophosphamide in the treatment of multiple sclerosis. CNS Neurosci Ther. 2009; 15(2):118-27. PMC: 6494060. DOI: 10.1111/j.1755-5949.2008.00072.x. View

16.

Gladstone D, Prestrud A, Pradhan A, Styler M, Topolsky D, Crilley P . High-dose cyclophosphamide for severe systemic lupus erythematosus. Lupus. 2002; 11(7):405-10. DOI: 10.1191/0961203302lu229oa. View

17.

Mittal G, Balakrishna C, Mangat G, Joshi V . 'Sustained remission' in a case of SLE following megadose cyclophosphamide. Lupus. 1999; 8(1):77-80. DOI: 10.1191/096120399678847326. View

18.

Savage W, DeRusso P, Resar L, Chen A, Higman M, Loeb D . Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide. Pediatr Blood Cancer. 2007; 49(7):947-51. DOI: 10.1002/pbc.21143. View

19.

Breban M, Dougados M, Picard F, Zompi S, Marolleau J, Bocaccio C . Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthritis Rheum. 1999; 42(11):2275-80. DOI: 10.1002/1529-0131(199911)42:11<2275::AID-ANR3>3.0.CO;2-6. View

20.

Brannagan 3rd T, Alaedini A, Gladstone D . High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve. 2006; 34(2):246-50. DOI: 10.1002/mus.20524. View